Click here for Somavert® (pegvisomant) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.
Somavert is used in the treatment of adult patients with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalise IGF-I concentrations or was not tolerated.
A loading dose of 80mg Somavert should be administered subcutaneously under medical supervision. Following this, 10mg Somavert should be administered once daily as a sub-cutaneous injection.
Dose adjustments should be based on serum IGF-I levels. Serum IGF-I concentrations should be measured every four to six weeks and appropriate dose adjustments made in increments of 5 mg/day in order to maintain the serum IGF-I concentration within the age-adjusted normal range and to maintain an optimal therapeutic response.1
The dose range of Somavert is 10-30mg daily. The maximum dose should not exceed 30mg/day.1
†Please refer to the Summary of Product Characteristics for the full information regarding storage
We offer a range of services that help your patients at home with medication delivery and face-to-face support
Find information on funding, homecare and follow-up
Discover IGF-I normalisation rates with Somavert
To find out more about Somavert dosing, supporting your patients or to order starter kits
** This is an optional area where footnotes can live.
Track IGF-I, symptoms and co-morbidities to help monitor and optimise support for your acromegaly patients at every stage of their journey
** This is an optional area where footnotes can live.
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021
No
OK, We will need you to sign in before we can determine if you are aligned with a Pfizer promotional colleague.This is an interstitial message to prompt a HCP before they login.
If you have already registered with pfizerpro.co.uk and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.
Would you like to register or sign in now?